The aim of the study is to define the ability of Flt3 ligand, MGDF, Epo and G-CSF to modulate the expansion of different hematopoietic compartments in association with a basic cocktail of SCF + IL-3 + IL-6 (S36).
The central question in ex vivo hematopoietic cell expansion is the effective capacity of the culture system to expand not only progenitor and precursor cell populations, but also the primitive compartment. In particular, it remains to be demonstrated whether the various combinations of growth factors employed are able to amplify the granulopoietic, erythropoietic and megakaryopoietic pools without exhausting the stem cell pool.
1-4
Using well-defined experimental conditions and highly purified hematopoietic stem cell preparations, the roles of different cytokines have been examined in detail. [5] [6] [7] [8] It was established that optimal ex vivo growth of primitive progenitors could only be achieved through the use of the interactions of several cytokines.
9-11 Stem cell factor (SCF) was found to be essential for primitive stem cell maintenance and to combine with lineage-restricted cytokines 8, 12, 13 to efficiently recruit progenitors of high proliferative capacity. The combination SCF + IL-3 + IL-6 (S36) had also been previously shown to significantly increase precursor and progenitor cell compartments. 14, 15 Similarly, Flt3 ligand (FL) was demonstrated to synergize with SCF, interleukin-3 (IL-3) and interleukin-6 (IL-6) to enhance the growth of primitive hematopoietic cells. 16, 17 Some cytokines, initially described as lineage restricted, have since been found to contribute to the triggering of the cell cycle of dormant multipotential progenitors by synergizing with other factors. [18] [19] [20] [21] This is the case of Mpl-ligand or MGDF, which is now known to act on the megakaryocytic lineage. 22 In the present study, we examined the ability of various combinations of cytokines (FL, MGDF, Epo and G-CSF), associated with a basic cocktail of S36, to stimulate all hematopoietic compartments. Attention was focused in particular on the respective roles of the different growth factors and on the stimulation of specific compartments. FL, MGDF, Epo and G-CSF were found to be critical for successful expansion in the presence of S36, in order to allow the progeny cells to retain the pluripotent differentiation and self-renewal capacities of the original stem cells.
Materials and methods

Bone marrow (BM) cell preparation
BM cells were obtained with informed consent from healthy donors. Low-density mononuclear cells (MNCs) were separated on a Ficoll-Isopaque density gradient (1.077 g/ml; Seromed, Biochrom, Berlin, Germany), washed and resuspended at a concentration of 1-5 ϫ 10 7 /ml in RPMI 1640 (Gibco, Life Technologies, Paisley, UK). CD34 + cells were selected using the Isolex TM 50 procedure (Baxter, Fenwal Division, Deerfield, IL, USA) as previously described 15 and the mean CD34 + cell purity was 92 Ϯ 2%.
Liquid cultures
CD34
+ cells (2.5 ϫ 10 3 per well) were suspended in sixwell plates (Falcon, Heidelberg, Germany) in a mixture (1.5 ml per well) containing serum-free long-term culture medium (LTCM), 23 and various combinations of cytokines. Cultures were incubated at 37°C in a 100% humidified, 5% CO 2 atmosphere for 10 days. On day 6, an equal volume of fresh LTCM and cytokines was added to each well. Total cells were collected on day 10, washed in Iscove's modified Dulbecco's medium (IMDM; Seromed, Biochrom), counted by trypan blue exclusion and assayed for progenitor cells, LTC-IC and immunophenotype.
Cytokines
Cultures contained various mixtures of the following recombinant human growth factors. Mast growth factor or stem cell factor (SCF) (100 ng/ml) and Flt3 ligand (FL) (100 ng/ml) were kindly provided by Immunex (Washington, USA), Megakaryocyte growth and development factor (MGDF) (100 ng/ml) by Amgen (Thousand Oaks, CA, USA), IL-3 (5 ng/ml) and IL-6 (10 ng/ml) by Sandoz (Basel, Switzerland), G-CSF (10 ng/ml) by Shugai Rhône-Poulenc (Ukima, Japan) and Epo (0.5 ng/ml) by Behring (Marburg, Germany).
Progenitor cell assays
Burst-forming unit-erythroid cells (BFU-E) and colonyforming unit-granulocyte-macrophage (CFU-GM) were assayed in single-layer methylcellulose cultures according to Eaves and Eaves. 24 Cells were stimulated with 20 ng/ml G-CSF and GM-CSF (Shugai Rhône-Poulenc), 10 ng/ml IL-3, 3 U/ml Epo and 50 ng/ml SCF. Cell concentrations were 0.5-1 ϫ 10 3 CD34 + cells/ml on day 0 and 2 ϫ 10 3 -5 ϫ 10 4 cells/ml on day 10. BFU-E and CFU-GM were scored on day 14 of culture.
Colony-forming unit-megakaryocyte (CFU-MK) were assayed in a plasma clot culture system according to Mitjavila et al. 25 Cells were stimulated with 10% preselected serum from aplastic patients, 20 ng/ml IL-3, 20 ng/ml IL-6 and 50 ng/ml SCF. Cell concentrations were 10 4 CD34 + cells/ml on day 0 and 2-5 ϫ 10 5 cells/ml on day 10. Colonies containing three or more CD61-positive cells were scored on day 12 of culture.
Limiting dilution assay for long-term bone marrow culture-initiating cells (LTC-IC) and extended-LTC-IC (E-LTC-IC)
LTC-IC were assayed using a slight modification of Sutherland's method 26 and performed on stroma layers established with a murine cell line (MS5) generously provided by K Mori (Department of Biology, Faculty of Science, Niigata University, Japan). This cell line, which is known to sustain long-term cultures of human cells, 27 was suspended in 5 ml ␣MEM (Gibco) supplemented with 10% FCS in 25 cm 2 tissue culture flasks (Falcon). The cells were fed until the flasks reached confluence. Adherent cells were then trypsinized (Gibco) and replated in 96-well plates coated with 1% gelatine. On days 0 and 10 of culture, cells were seeded on the preformed feeder. Cultures were initiated in IMDM supplemented with 1% l-glutamine, 12.5% FCS and 12.5% HS (Costar, Brumath, France), kept for 4 days at 37°C and subsequently transferred to 33°C, at all times in a 5% CO 2 atmosphere. At weekly intervals, the wells were fed by replacing half the medium. After 5 weeks of culture, the progenitor content of each well was scored by overlaying with methylcellulose medium containing SCF, IL-3, G-CSF, GM-CSF and Epo, as described above. The LTC-IC frequency was determined by scaling the cultures down to a volume of 100 l in 96-well microtiter plates and performing limiting dilution assays with 20 to 50 replicates per step. Dilution steps were 100, 50, 25, 10 and five cells/well for the CD34 + fraction of day 0. The expanded population was assayed from 100 to 8 ϫ 10 4 cells/well, taking into account the cell expansion rate. The absolute number of LTC-IC was calculated from the concentrations of cells that gave 37% negative wells, using Poisson statistics. The CFC-generating capacity of LTC-IC was assessed by scoring the progenitors from all the dilutions that gave у37% negative wells (ie total CFC produced in n wells at dilutions that gave у37% negative wells/total LTC-IC in n wells, where total LTC-IC is obtained from the frequency of LTC-IC and the total number of cells in the experiment). To assay the E-LTC-IC, cells were maintained in similar conditions for 10 weeks on the MS5 stroma. The CFCgenerating capacity of LTC-IC was determined as well.
Flow cytometry
Initial and cultured cells were labeled with the following combinations of monoclonal antibodies: phycoerythrin (PE)-CD34 (Anti-HPCA-2; Becton Dickinson, San Jose, CA, USA), fluorescein isothiocyanate (FITC)-CD45, FITC-CD15 (Becton Dickinson), PE-CD33, PE-CD13, PE-CD14 (Becton Dickinson) and FITC-GlyA FITC-CD41A (Immunotech, Marseille, France). Isotype-matched FITC and PE-conjugated antibodies were used as controls. Cells were counted with a FACScan flow cytometer (Becton Dickinson) and 10 000 events per sample were analyzed using Cell Quest software. Gates were set to forward light scatter (FSC) and side light scatter (SSC) to exclude noncellular particles, the proportions of cells expressing the various surface markers being estimated from the fluorescence intensity of gates 1 or 2 relative to the intensity of SSC.
Data analysis
The results were expressed as fold increase by dividing the output number of cells, progenitors and LTC-ICs obtained at day 10 of culture by the respective input number at day 0. Statistical analyses were performed using the SPSS stat-istical package. In order to examine the effects of individual growth factors on hematopoietic cell expansion, analysis of variance was carried out using a general factorial method. Analyses were performed separately for each type of cell and all possible major effects and interactions were included in a full factorial design. A logarithmic transformation of the results was employed in these calculations. Parameter estimates were computed by comparing the presence of each growth factor to the reference level in the absence of this factor S36, while multiple comparisons were obtained by calculating confidence intervals for the different parameters using the Bonferroni correction. 28 On account of the small number of LTC-IC measurements, a multiparametric analysis could not be performed and hence the non-parametric Fisher test was applied.
Results
CD34
+ cells derived from normal bone marrow were cultured in stroma-free, serum-free medium and supplemented with S36, in the presence or absence of various combinations of Flt3 ligand, MGDF, Epo and G-CSF. Data for precursor cell, progenitor cell and LTC-IC expansion are presented in Figures 1 and 2 and Table 1 , respectively. As seen, several combinations of these four cytokines (FL, MGDF, Epo and G-CSF) added to a basic cocktail of S36 can induce important expansion of all hematopoietic compartments after 10 days of culture. A multiparametric study was performed with the aim of comparing the level of expansion obtained in the presence of each growth factor (FL, MGDF, Epo or G-CSF) to the level observed with the basic cocktail S36 alone. When interactions between factors were apparent, further analyses were carried out to identify synergistic and negative effects.
Effects on the late precursor cell compartment
Three factors had a significant stimulatory action on the late precursor cell compartment (Figure 1) . A statistical increase in the level of total cell expansion was obtained by adding Epo (P Ͻ 10
) as compared to S36 alone. Significant interaction was observed between FL and G-CSF only in the absence of Epo, while Epo itself appeared to exert a potent effect on the erythroid compartment by increasing the percentage of glycoA + cells (P Ͻ 10
Ϫ5
). In contrast, in the absence of Epo, FL exhibited an inhibitory action on this compartment (P = 0.022). It should also be noted that the stimulating effect of Epo was not reduced by MGDF. Interestingly, MGDF appeared to have a stimulatory influence (P = 0.052) in the absence of Epo. The percentage of CD33 + cells was significantly enhanced (P = 4 ϫ 10
Ϫ4
) in the presence of FL, whereas Epo decreased (P Ͻ 10
Ϫ5
) the expansion of this compartment. Due to the very small number of megakaryocytes, CD41 + cells, it was not possible to reliably analyze the effects of the different combinations of cytokines on this compartment, the most important expansion being 7% (0.2 to 17) with the S36 FMEG combination. + marker and plated in semisolid colony assays for CFU-GM and BFU-E determination. Results from four to 15 separate experiments are expressed in terms of the median fold expansion (range) on day 10 relative to day 0. On day 0, 5 to 100 CD34 + cells/well and on day 10, 100 to 80 000 expanded cells/well were seeded on the performed stroma MS5. After 5 weeks of culture, the progenitor content of each well was scored as described in Materials and methods. The frequency of LTC-IC was calculated using Poisson statistics, while the number of CFC per LTC-IC (CFC/LTC-IC) was determined by scoring the progenitors in wells containing no more than one LTC-IC. a Results expressed in terms of fold expansion on day 10 relative to day 0. S = SCF; 3 = IL3; 6 = IL6; G = G-CSF; E = Epo; M = MGDF; F = Flt3 ligand; NA = not available.
Effects on the progenitor cell compartment
In the case of the progenitor cell compartment (Figure 2) , we found FL and Epo to exert a similar stimulatory influence on the expansion of CD34 + cells (P = 4 ϫ 10 Ϫ5 and P = 6 ϫ 10 Ϫ5 , respectively), without any apparent mutual interaction. Adding only FL strongly stimulated CFU-GM expansion (P Ͻ 10 Ϫ5 ), while both MGDF and FL significantly increased BFU-E expansion (P = 8 ϫ 10 Ϫ4 and P = 0.017, respectively). No additive effect between MGDF and FL was observed on BFU-E expansion. None of the growth factors studied (FL, MGDF, Epo or G-CSF) significantly stimulated or inhibited CFU-MK expansion (one-to fivefold). It is noteworthy that in the presence of FL, whatever the combination of other growth factors, the size of CFU-GM and BFU-E colonies was similar (Ͼ300 cells/colony) on day 10, whereas CFU-MK colonies in all cases decreased in size after ex vivo expansion, from about 30 to three cells/colony.
Effects on the primitive cell compartment
The two factors FL and MGDF had a significant effect on LTC-IC expansion (Table 1) . Extents of expansion were always Ͼ1 (12 experiments/12) in the presence of FL and Ͻ1 in its absence (8 experiments/8), with respective median levels of expansion of three-fold (1.8 to 4.4) and 0.6-fold (0.3 to 0.7) (P = 10 Ϫ4 ). In the presence of MGDF, the median level of expansion was 3.6-fold (3 to 4.4), as compared to 1.8-fold (0.3 to 3.2) (P = 0.002) in its absence. Moreover, the extent of expansion was in all cases (4 experiments/4) Ͼ3-fold in the presence of MGDF. In all experiments, the CFC-generating capacity of the expanded LTC-IC was maintained, with a mean level of 3.8 CFC/LTC-IC (2.3 to 5.6) on day 10 as compared to a mean level of 3.9 CFC/LTC-IC (2.7 to 4.5) on day 0.
In the light of the above results showing a preferential effect on CFU-GM, BFU-E and LTC-IC expansion, the combination FL + MGDF + Epo + G-CSF was chosen as a putative cytokine cocktail for addition to S36 and further studies were performed to test its efficacy. CD34
+ cells (2.5 ϫ 10 3 /1.5 ml) were suspended in six-well plates in the presence of S36 and the above cytokines. After 10 days of culture, the levels of expansion were 84-fold for CFU-GM, 11-fold for BFU-E, three-fold for CFU-MK and six-fold for LTC-IC with respect to day 0. Figure 3 shows the straight lines resulting from the limiting dilution assays for LTC-IC before and after expansion. In an attempt to distinguish between preservation or expansion of the primitive pool, the following experiment was performed. On day 14, total cells were harvested and half were transferred to a new stroma-free well containing an equal volume of fresh medium supplemented with the same cytokines and the same operation was repeated weekly up to exhaustion of the culture (day 106). The cell suspensions were assayed at weekly intervals for progenitors and/or LTC-IC. As shown in Figure 4 , the progenitor and precursor compartments strongly expanded until day 106, reaching on day 85, a maximum expansion rate of 78 329-fold for total cells and on day 56, a maximum of 6841 fold for CFU-GM. The frequency (1/1332 to 1/5416) and CFC-generating capacity (2.5 to 3.4 CFC/1 LTC-IC) of LTC-IC remained constant at these levels up to the last day of evaluation (day 64). However the extent of expansion of LTC-IC was 70-fold relative to day 0 (Table 2) . Simultaneously, the frequency of CFU-GM in the supernatant was constant (1/109 to 1/320) until day 71, but then decreased to 1/1083 on day 106. In an attempt to confirm the expansion of the very primitive pool, a similar additional experiment was performed, focusing on the evaluation of E-LTC-IC at day 14, and on day 35 when the LTC-IC expansion was maximum. Data on Table 3 show the reproducible high level of expansion of precursor, progenitor and LTC-IC pools, with an E-LTC-IC extent of expansion four-fold and five-fold on days 14 and 35, respectively.
Discussion
The present study was conducted to investigate the impact of FL, MGDF, Epo and G-CSF in association with a basic cocktail of S36, on the stimulation of hematopoietic compartments. Our aim was to define the ability of each growth factor to modulate the expansion of different hematopoietic compartments, under conditions corresponding to the simultaneous addition of several cytokines. The results were therefore subjected to a general analysis of variance. In the stroma-free, serum-free conditions of our experiments, the three cytokines Epo, G-CSF and FL appeared to significantly influence the expansion capacity of the late precursor compartment (total cells) giving 11.4-fold, 1.75-fold and 1.6-fold increases in expansion rate, respectively, as compared to S36 alone. FL exhibited a particular effect on the granulopoietic compartment (CD33 + ) (2.15-fold), while Epo strongly stimulated the erythropoietic (glyco A + ) pathway (114-fold) relative to S36 alone, in accordance with Brugger et al's results. 29 In spite of some negative interactions between factors, which can slightly modify the overall expansion, our data would favor the combined use of FL, Epo and G-CSF to simultaneously expand the late granulopoietic and erythropoietic compartments. These observations are in accordance with McKenna et al's report that FL induced the formation of myeloid colonies and + cells/1.5 ml were seeded on day 0 in six-well plates in serum-free, stroma-free culture medium containing SCF, IL-3, IL-6, Epo, G-CSF, MGDF and FL. At weekly intervals, half the cells were harvested, transferred to new six-well plates and refed with fresh medium containing the same cytokines. The remaining cells were analyzed for viability and progenitors. This procedure was repeated every week for 100 days and results are expressed as the fold increase relative to day 0. increased the total cell population. 30 G-CSF and Epo have been largely found to be lineage-specific, selectively stimulating neutrophil formation and erythroblast proliferation from earlier precursors, 31, 32 although Epo could have additional effects on mitosis or terminal differentiation. 32 In the simultaneous presence of all seven cytokines, expansion of the progenitor cell compartment was strongly influenced by FL, Epo and MGDF. FL was a critical cytokine for CD34
+ , CFU-GM and BFU-E expansion, inducing up to 4.4-fold, 4.3-fold and 2.6-fold increases respectively, as compared to S36 alone. Epo, on account of its marked stimulation of the total cell expansion, proved to be a critical factor for CD34 + cells. MGDF was a potent BFU-E stimulator, two-fold more effective than S36 alone, but without any effect on CFU-MK. However, among the cytokines studied none had any significant influence on CFU-MK expansion. MGDF was initially reported to be restricted to the MK lineage and to exhibit properties similar to those of thrombopoietin (Tpo), with little or no activity towards other lineages. [33] [34] [35] However, several groups have recently shown that myelopoiesis and erythropoiesis are also under MGDF control. 36, 37 Flt3 ligand has been found to enhance the growth of human progenitor cells, including CD34
+ cells and erythroid progenitors. 6, 16, 17, 38 Finally, antisense oligonucleotides to the human FL receptor display in vitro inhibition of CFU-GM and BFU-E. 39 Our study clearly demonstrated that two factors, FL and MGDF, have a major effect on LTC-IC expansion, giving reproducible expansion rate of three-to six-fold after 10 days culture. These results are in agreement with several reports. MGDF was found to support the formation of multilineage colonies from marrow cells of 5-fluorouraciltreated mice in synergy with SCF or IL-3, 22 while Mpl knockout mice have reduced numbers of multipotential progenitors relative to wild-type controls. 40 Moreover, MGDF can induce the proliferation of stem cell populations to achieve the long-term reconstitution of lethally irradiated mice 41 and can also promote viability and suppress apoptosis among primitive multipotent progenitor cells. 42 FL strongly synergized with SCF, IL-3 and IL-6 to induce the proliferation of CD34 + /38 Ϫ cells, thus enabling the expansion of CFC from LTC-IC. 43 As single factors, only FL and Tpo have been reported to stimulate the amplification of LTC-IC and CFC. 44 FL might in addition preferentially enhance the growth of primitive hematopoietic progenitor cells. 45 The maintenance and/or generation of LTC-IC has to date only been reported for single hyperselected CD34 + /38 Ϫ cells, cultured for 1-3 weeks in the absence of a stroma layer. 46 This established the possibility of LTC-IC selfrenewal division within a 6-week period and demonstrated a very high extent of expansion of LTC-IC (up to 50-fold) under these conditions. Unfortunately, such extents of expansion are not observed in clinical scale situations. LTC-IC expansion in bioreactor system was reported up to seven-fold, 47, 48 however this is the first study where levels of LTC-IC expansion of up to 80-fold at day 35 were achieved using high concentrations of low purity marrow cells. Our data show that total CD34
+ cells can be stimulated by cytokines in stroma-free, serum-free culture to produce high levels of primitive cells. The capacity of a 10-day expanded human population to produce such quantities of precursor/progenitor cells for more than 100 days reflects at least the persistence and probably the expansion of primitive stem cells, which further suggests that these populations could undergo self-renewal divisions. The LTC-IC detected in our study at a frequency of 1/5416 on day 64 (0.02% of total cells) probably represent cell populations similar to the self-renewing LTC-IC described by Petzer et al 46 reporting that 2% of CD34 + /38 low cells (0.02% of mononuclear cells) are capable of self-renewal when cultured 6 or 12 weeks on engineered murine fibroblasts. Moreover the expansion of the primitive pool in our experimental condition is confirmed by the four-to five-fold expansion of the E-LTC-IC population, recently reported by Hao et al 49 as a very primitive hematopoietic stem cell producing CFC after 60 days, and candidate for the most primitive human population evaluable in vitro. Indeed, the NOD/SCID model will be essential to define primitive human hematopoietic cells, since CFC and LTC-IC are easily transduced but do not contribute to the repopulation of engrafted mice. 50 In conclusion, a combination of FL, MGDF, Epo and G-CSF in the presence of SCF + IL-3 + IL-6 meets the required criterion for potential clinical application which may be defined as an effective capacity to expand precursor, progenitor and LTC-IC compartments at the same time. Our results show that after 10 days of expansion high concentrations (2500 cells/1.5 ml) of low purity cells (CD34 + ) allow the expansion of total cells up to 3080-fold, CD34 + cells up to 53-fold, CFU-GM up to 134-fold, BFU-E up to 46-fold, CFU-MK up to five-fold and LTC-IC up to sixfold without loss of their CFC-generating capacity. As part of our current experimental studies aimed at establishing reliable conditions for clinical cell culture, these data provide the rationale to suggest use of these seven growth factors in clinical applications of expanded hematopoietic cells.
